Effects of robenidine and some other drugs on mice experimentally infected with toxoplasma.
D000284:Administration, Oral; D000670:Amprolium / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use; D001921:Brain / Q000469:parasitology; D002264:Carboxylic Acids / Q000627:therapeutic use; D002722:Chlorobenzenes / Q000627:therapeutic use; D004987:Ethers / Q000627:therapeutic use; D005243:Feces / Q000469:parasitology; D006146:Guanidines / Q000008:administration & dosage / Q000627:therapeutic use*; D007274:Injections, Intraperitoneal; D051379:Mice; D009578:Nitrobenzenes / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D011804:Quinolines / Q000627:therapeutic use; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013424:Sulfanilamides / Q000031:analogs & derivatives / Q000627:therapeutic use; D014124:Toxoplasmosis, Animal / Q000188:drug therapy* / Q000209:etiology / Q000469:parasitology
D000981:Antiprotozoal Agents; D001549:Benzamides; D002264:Carboxylic Acids; D002722:Chlorobenzenes; D004987:Ethers; D006146:Guanidines; D009578:Nitrobenzenes; D011725:Pyridines; D011743:Pyrimidines; D011804:Quinolines; D013424:Sulfanilamides; D013412:Sulfadimethoxine; D000670:Amprolium